Example: Heart Attack
Search clinical trials for: Chlorpheniramine, phenylpropanolamine drug combination
Total 0 results
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Acute Coronary Lesion
- Ciliary Dyskinesia
- High Fidelity Simulation Training
- Injury as a Result of Positioning
- Lacrimal Tumor
- Lymphoma (Hodgkin's and Non-Hodgkin's)
- Mechanical Ventilation for More Than 48 Hours.
- Neoadjuvant Treatment
- Novel H1N1 Influenzal Acute Respiratory Infection
- Pain Relief
- Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
- Sleeve Gastrectomy
- TLK2
- View Full List
Sponsors and Collaborators
- 22EON
- Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
- Cambia Health Solutions
- Center for Nutritional Medicine Tuebingen/Hohenheim
- Centre for Contact Lens Research
- L'Oreal
- Liverpool Clinical Trials Unit
- Malcolm Kohler
- Peter MacCallum Cancer Institute
- Procitech
- Variant Bio, Inc.
- WellStar Health System
- iHealthScreen Inc
- View Full List
Drug Interventions
- BLZ-100
- Biguanide (BG)
- Brexpiprazole, OPDC-34712
- Docetaxel and Cyclophosphamide (TC)
- Etanercept inhibition of ozone-induced airway hyper-responsiveness.
- IOC
- Implant
- LUTATHERA® by intra-arterial hepatic (IAH) injection
- Metformin HCL Tablets, 1000 mg Sandoz
- Oxaliplatin, LV, 5-FU
- PF-06669571
- Ritonavir boosted Atazanavir + Lamivudine
- Tipepidine Hibenzate
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations